Trelagliptin 50mg and 100mg (Trelaglip)
0.00$
Wedica is a dipeptidyl peptidase-IV (DPP-4) inhibitor that is taken once weekly. It works by selectively and consistently inhibiting DPP-4, an enzyme responsible for deactivating incretin hormones such as glucagon-like peptide-1 and glucagon-dependent insulinotropic polypeptide. These hormones are essential for regulating blood glucose levels. By blocking DPP-4, Wedica helps increase insulin secretion in response to blood glucose levels, effectively managing blood sugar. It is supplied in tablet form for oral use.
Trelagliptin, which is retailed under the trade name Trelaglip, is an oral hypoglycemic medicine that’s used in the operation of type 2 diabetes mellitus( T2DM). It’s a Dipeptidyl Peptidase- 4( DPP- 4) asset and has the distinction of having a formerly-daily dosing authority, making it a more accessible treatment option compared to formerly- diurnal DPP- 4 impediments. Trelaglip is available in 50 mg and 100 mg tablet strengths and is taken as part of a total diabetes control authority that includes diet, exercise, and maybe other antidiabetic specifics.
Mechanism of Action
Trelagliptin inhibits the enzyme DPP- 4 that inactivates incretin hormones similar as GLP- 1( glucagon- suchlike peptide- 1) and GIP( glucose-dependent insulinotropic polypeptide). These hormones induce the release of insulin and suppress the release of glucagon during food input and keep blood glucose situations under control.
Trelaglip’s inhibition of DPP- 4 increases the situations and duration of action of incretins. This leads to
Pancreatic beta-cells’ raised stashing of insulin.
nascence- cells’ reduced stashing of glucagon.
drop fasting and postprandial blood glucose situations.
The extended half-life of Trelagliptin enables formerly-daily dosing, which increases patient compliance and convenience.
Indications
Trelaglip( Trelagliptin) is indicated for the treatment of
Type 2 diabetes mellitus( T2DM) in grown-ups as an adjunct to diet and exercise to ameliorate glycemic control.
It may be used as monotherapy or combination remedy with other antidiabetic specifics, including metformin, sulfonylureas, thiazolidinediones, or insulin, when diet and exercise aren’t enough to give acceptable glycemic control.
Dosage and Administration
Trelaglip is available as 50 mg and 100 mg tablets for oral use. The cure should be initiated at 100 mg once a week with or without food. In some cases, 50 mg might be an applicable lozenge depending on renal function or other patient factors.
Important administration instructions
In order to maintain steady blood situations, the tablet should be taken on the same day of each week.
still, it can be taken as soon as possible, If a cure is missed and recalled within 3 days.However, skip the missed cure and take the coming cure on the usual day, If further than 3 days.
Don’t take two boluses in the same week.
Pharmacokinetics
Immersion Trelagliptin 50mg and 100mg (Trelaglip) is fleetly absorbed after oral administration, and maximum tube attention are generally reached within 1 to 2 hours.
Half- It’s roughly 5 days terminal half-life, which explains its formerly-daily dosing.
Metabolism Trelagliptin isn’t significantly hepatically metabolized.
Excretion It’s excreted primarily via the renal route, with a cure adaptation demanded in cases with severe renal impairment.
Efficacy
Clinical trials have shown that Trelagliptin is effective at reducing HbA1c and fasting tube glucose with dragged use. It’s as effective as formerly- diurnal DPP- 4 impediments like sitagliptin or saxagliptin. formerly-daily dosing also enhances patient compliance and treatment satisfaction.
Safety and Side Goods
Trelaglip is safe and well permitted. Generally being side goods are
Nasopharyngitis
Headache
Upper respiratory tract infections
Less common but more severe adverse effects may be
Hypoglycemia( especially when used with sulfonylureas or insulin)
Pancreatitis( rare)
Acuity responses similar as rash or urticaria
Trelagliptin has a low threat of hypoglycemia when used as monotherapy.
Contraindications and Precautions
Contraindications
Given acuity to trelagliptin or any element of the expression.
Type 1 diabetes mellitus
Diabetic ketoacidosis
preventives
Renal impairment: Use with caution; may need dose reduction.
Hepatic impairment Limited data; use with caution.
gestation and lactation. Use only if surely indicated and under medical supervision.
Regular monitoring of blood glucose and HbA1c is recommended during treatment.
Drug Interactions
Trelaglip has low eventuality for medicine- medicine relations because it undergoes little hepatic metabolism. Still, use with caution in combination with
Insulin or insulin secretagogues( threat of hypoglycemia)
Medicines that affect renal function
Advantages of Trelaglip
Once-daily dosing improves compliance.
Provides good glycemic control with minimal threat for weight gain.
Low threat for hypoglycemia when used as monotherapy.
Well- permitted with a good safety profile.
Conclusion
Trelagliptin( Trelaglip) 50 mg and 100 mg is a new and patient-friendly formerly-daily treatment for type 2 diabetes. It’s as effective as other DPP- 4 impediments with the added benefit of increased adherence and convenience. As with all antidiabetic specifics, it must be specified as part of an personalized treatment plan according to patient need and on a regular base covered for efficacity and safety.
Order Now At Mdx Pharma bd….
To order from MDX Pharma BD, visit their website at https://mdxpharmabd.com, where you can browse products and place orders online. For inquiries or orders via email, contact emedicarepharma@gmail.com. Alternatively, call (+88) 01929123476. Their address is 29, Abdullahpur, Uttara, Dhaka-1230, Bangladesh.
1. What’s Trelagliptin( Trelaglip)?
Trelagliptin is a formerly-daily DPP- 4 asset used to manage blood sugar situations in cases with type 2 diabetes. It stimulates insulin release and reduces glucagon situations after refections.
2. How does Trelagliptin work?
Trelagliptin inhibits the action of the enzyme DPP- 4, which degrades incretin hormones. This augments the effect of incretin by its extension, causing increased insulin release and reducing blood glucose after a meal.
3. What’s the difference between the 50 mg and 100 mg boluses?
A dose of 50 mg can also be administered to cases who bear a lower dose due to renal impairment or some other reason. Still, the standard cure for utmost cases is 100 mg once a week.
4. Can one take Trelagliptin together with another diabetes drug?
Yes. Trelagliptin can be specified alone or in combination with other antidiabetic specifics like metformin, sulfonylureas, or insulin, as decided by a doctor.
5. Is Trelagliptin safe for people with order problems?
Trelagliptin is safe in cases with mild to moderate renal impairment, but cure adaptation or monitoring may be needed. Kindly consult a croaker for individual guidance.
6. Is Trelagliptin likely to cause hypoglycemia?
It has low eventuality to causing hypoglycemia when taken collectively. The threat is more with the attendant use of other specifics like insulin or sulfonylureas.
Product Name | Wedica |
---|---|
Generic Name | Trelagliptin Succinate |
Formulation | Tablet |
Available size | 2×10 ’s and 2×8’s |
Strengths | 50mg and 100mg |